NPI: 1487771812 · LAS VEGAS, NV 89149 · General Acute Care Hospital · NPI assigned 03/22/2007
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 03/22/2007 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 82,848 | $1.14M |
| 2019 | 226,367 | $4.29M |
| 2020 | 185,421 | $3.42M |
| 2021 | 201,465 | $4.16M |
| 2022 | 187,112 | $4.18M |
| 2023 | 193,227 | $4.28M |
| 2024 | 153,728 | $3.63M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 46,972 | 38,742 | $5.11M |
| G0378 | Hospital observation service, per hour | 20,654 | 14,593 | $2.45M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,148 | 23,194 | $2.23M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,313 | 7,888 | $2.15M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,368 | 21,398 | $1.30M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,011 | 8,333 | $834K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,035 | 2,560 | $725K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,760 | 4,086 | $699K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 36,309 | 28,016 | $588K |
| 96361 | Intravenous infusion, hydration; each additional hour | 26,975 | 19,610 | $550K |
| 96375 | Therapeutic injection; each additional sequential IV push | 30,332 | 21,204 | $532K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 911 | 755 | $411K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,080 | 10,606 | $289K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,120 | 6,460 | $246K |
| 59025 | Fetal non-stress test | 6,739 | 4,839 | $234K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 17,262 | 11,273 | $234K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,392 | 11,930 | $230K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 71,387 | 49,782 | $217K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,074 | 1,811 | $216K |
| 96376 | 15,444 | 7,918 | $213K | |
| 80053 | Comprehensive metabolic panel | 47,569 | 36,531 | $203K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6,614 | 5,736 | $203K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,858 | 2,444 | $169K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,502 | 4,406 | $157K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 34,847 | 26,832 | $154K |
| 71045 | Radiologic examination, chest; single view | 24,258 | 20,072 | $148K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,148 | 2,013 | $146K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,337 | 1,032 | $142K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,389 | 2,923 | $140K |
| 76830 | Ultrasound, transvaginal | 1,984 | 1,712 | $139K |
| 84484 | 32,469 | 17,678 | $136K | |
| 76801 | 2,331 | 1,955 | $135K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,572 | 2,218 | $126K |
| 71046 | Radiologic examination, chest; 2 views | 9,157 | 8,031 | $118K |
| 84702 | 20,274 | 16,883 | $116K | |
| 36415 | Collection of venous blood by venipuncture | 85,613 | 54,164 | $115K |
| 0450 | Emergency room services | 2,317 | 2,049 | $113K |
| 70496 | 355 | 321 | $109K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 513 | 457 | $105K |
| 95819 | 650 | 426 | $103K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,542 | 1,296 | $93K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 411 | 328 | $90K |
| 70498 | 344 | 312 | $82K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 26,063 | 18,923 | $82K |
| 93971 | 1,780 | 1,535 | $81K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,522 | 2,947 | $77K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 894 | 742 | $68K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,198 | 996 | $67K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,343 | 1,502 | $66K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,198 | 1,735 | $66K |
| 72131 | 506 | 471 | $65K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,806 | 1,460 | $65K |
| 83690 | 21,098 | 17,082 | $61K | |
| 83880 | 5,581 | 4,574 | $60K | |
| 97161 | 2,496 | 1,964 | $60K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,244 | 2,838 | $58K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 21,513 | 13,707 | $56K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,169 | 539 | $56K |
| 93970 | 719 | 632 | $53K | |
| 83605 | 10,724 | 8,011 | $44K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 888 | 803 | $44K |
| 97165 | 1,759 | 1,381 | $43K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,116 | 10,259 | $41K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,081 | 2,898 | $40K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,779 | 1,660 | $40K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 433 | 386 | $40K |
| 81001 | 28,952 | 24,177 | $39K | |
| 90715 | 995 | 883 | $38K | |
| 73564 | 1,838 | 1,655 | $37K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,456 | 1,159 | $35K |
| 47562 | 29 | 25 | $34K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,622 | 3,047 | $34K |
| 97162 | 1,218 | 1,018 | $31K | |
| 85730 | 15,930 | 12,395 | $30K | |
| 83735 | 13,618 | 8,577 | $28K | |
| 70486 | 240 | 211 | $28K | |
| 81025 | 11,529 | 9,781 | $28K | |
| 87040 | 6,306 | 3,368 | $27K | |
| 85379 | 6,459 | 5,546 | $27K | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 470 | 304 | $26K |
| 73630 | 1,608 | 1,448 | $25K | |
| 73610 | 1,401 | 1,269 | $25K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 313 | 250 | $24K |
| 85610 | 19,037 | 14,509 | $23K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,254 | 4,425 | $22K |
| 73130 | 1,162 | 1,053 | $20K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,208 | 1,018 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,205 | 1,017 | $20K |
| 47563 | 14 | 13 | $17K | |
| 73030 | 1,290 | 1,133 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,145 | 2,606 | $17K |
| 97166 | 644 | 561 | $17K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,501 | 5,124 | $16K |
| 80076 | 5,036 | 4,155 | $16K | |
| 93017 | 949 | 783 | $15K | |
| 87186 | 4,257 | 3,012 | $15K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 12,011 | 9,931 | $14K |
| 73110 | 667 | 610 | $14K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 517 | 329 | $14K |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,492 | 839 | $13K |
| 97535 | Self-care/home management training, each 15 minutes | 1,242 | 874 | $13K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 241 | 208 | $12K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,598 | 1,161 | $12K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 974 | 783 | $12K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8,477 | 7,481 | $12K |
| 80061 | Lipid panel | 2,946 | 2,336 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 30,427 | 21,763 | $11K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,688 | 889 | $11K |
| 82962 | 16,076 | 5,911 | $11K | |
| 43235 | 44 | 44 | $11K | |
| 87641 | 1,732 | 1,210 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 983 | 875 | $10K |
| 82550 | 4,091 | 3,203 | $10K | |
| 81003 | 10,858 | 9,054 | $10K | |
| 84145 | 1,038 | 818 | $10K | |
| 72100 | 656 | 564 | $10K | |
| 70491 | 57 | 52 | $9K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 2,446 | 1,547 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 503 | 156 | $9K |
| 85027 | 7,211 | 5,121 | $8K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 12,201 | 9,990 | $8K |
| 74018 | 798 | 646 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,925 | 2,390 | $8K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 44 | 41 | $7K |
| 82803 | 1,114 | 888 | $7K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,423 | 2,526 | $7K |
| 97116 | 845 | 643 | $7K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,721 | 830 | $7K |
| 86140 | 3,268 | 2,630 | $6K | |
| 74174 | 12 | 12 | $6K | |
| 86901 | 6,959 | 5,744 | $6K | |
| 87077 | 1,522 | 1,264 | $6K | |
| 86900 | 6,850 | 5,637 | $6K | |
| 97597 | 627 | 340 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,881 | 7,673 | $6K |
| J2704 | Injection, propofol, 10 mg | 9,521 | 7,575 | $6K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 948 | 773 | $5K |
| 80069 | 2,884 | 1,417 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 6,722 | 5,202 | $5K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 72 | 68 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,462 | 1,289 | $5K |
| 86850 | 5,119 | 4,151 | $5K | |
| 74022 | 203 | 167 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,708 | 4,526 | $5K |
| 87210 | 2,061 | 1,768 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,379 | 3,986 | $4K |
| 84439 | 1,172 | 1,008 | $4K | |
| 82330 | 735 | 612 | $3K | |
| 84100 | 2,119 | 1,538 | $3K | |
| 94644 | 158 | 121 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 51 | 49 | $3K |
| 73080 | 170 | 157 | $3K | |
| 93880 | 36 | 32 | $3K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 2,580 | 2,049 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 86 | 78 | $3K |
| J2060 | Injection, lorazepam, 2 mg | 5,058 | 3,530 | $3K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,423 | 1,040 | $3K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,086 | 2,612 | $3K |
| A9585 | Injection, gadobutrol, 0.1 ml | 87 | 67 | $3K |
| 84132 | 2,736 | 1,986 | $3K | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,088 | 1,191 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 123 | 118 | $2K |
| 96367 | 154 | 127 | $2K | |
| J3490 | Unclassified drugs | 202 | 149 | $2K |
| 82140 | 452 | 345 | $2K | |
| 87276 | 512 | 470 | $2K | |
| 87275 | 512 | 470 | $2K | |
| 29125 | 64 | 55 | $2K | |
| 73502 | 95 | 89 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 730 | 618 | $2K |
| 72040 | 111 | 94 | $2K | |
| 87631 | 1,121 | 935 | $1K | |
| 87070 | 710 | 547 | $1K | |
| 76775 | 66 | 62 | $1K | |
| 87205 | 1,192 | 851 | $1K | |
| J1630 | Injection, haloperidol, up to 5 mg | 1,050 | 677 | $1K |
| 85652 | 1,456 | 1,172 | $1K | |
| 82607 | 318 | 229 | $1K | |
| J1790 | Injection, droperidol, up to 5 mg | 201 | 179 | $1K |
| 82728 | 283 | 193 | $1K | |
| 84112 | 90 | 76 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | 17 | 12 | $1K |
| 82570 | 504 | 401 | $1K | |
| 84295 | 953 | 745 | $1K | |
| 73590 | 99 | 92 | $1K | |
| 85018 | 1,898 | 1,381 | $1K | |
| 85014 | 1,840 | 1,347 | $1K | |
| 12001 | 27 | 25 | $986.36 | |
| J0456 | Injection, azithromycin, 500 mg | 328 | 205 | $980.52 |
| 82746 | 245 | 174 | $969.06 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 504 | 328 | $911.62 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,154 | 911 | $910.67 |
| 84550 | 401 | 326 | $857.19 | |
| 85384 | 534 | 473 | $852.45 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 18 | 16 | $798.99 |
| J1953 | Injection, levetiracetam, 10 mg | 216 | 129 | $775.38 |
| 92610 | 29 | 26 | $714.61 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 156 | 130 | $695.57 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,626 | 5,319 | $665.47 |
| 87563 | 42 | 41 | $653.58 | |
| 87081 | 365 | 284 | $650.38 | |
| J3480 | Injection, potassium chloride, per 2 meq | 422 | 296 | $632.60 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 358 | 327 | $623.96 |
| 87430 | 164 | 152 | $607.42 | |
| 80074 | 80 | 53 | $604.94 | |
| 87420 | 125 | 115 | $603.02 | |
| 71101 | 26 | 25 | $581.40 | |
| 94664 | 59 | 46 | $545.50 | |
| 82010 | 127 | 114 | $534.43 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 29 | 24 | $531.10 |
| J1940 | Injection, furosemide, up to 20 mg | 574 | 226 | $511.81 |
| 12011 | 12 | 12 | $481.46 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 148 | 136 | $466.53 |
| 73090 | 35 | 29 | $457.06 | |
| 84156 | 290 | 234 | $455.34 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 582 | 503 | $430.68 |
| Q0114 | Fern test | 32 | 27 | $392.14 |
| J7510 | Prednisolone oral, per 5 mg | 16 | 16 | $375.46 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 139 | 92 | $307.75 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 57 | 24 | $300.62 |
| 83615 | 133 | 105 | $283.20 | |
| 86038 | 74 | 55 | $283.12 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 57 | 37 | $278.01 |
| 82731 | 18 | 13 | $256.04 | |
| 0250 | 96 | 24 | $253.98 | |
| G0008 | Administration of influenza virus vaccine | 48 | 43 | $253.80 |
| J3360 | Injection, diazepam, up to 5 mg | 20 | 18 | $252.57 |
| 82553 | 47 | 26 | $252.16 | |
| 90686 | 47 | 42 | $210.47 | |
| A9270 | Non-covered item or service | 15,470 | 2,587 | $209.97 |
| C1769 | Guide wire | 195 | 172 | $155.27 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 42 | 28 | $135.15 |
| J1836 | Injection, metronidazole, 10 mg | 282 | 217 | $114.45 |
| J1171 | Injection, hydromorphone, 0.1 mg | 109 | 91 | $76.60 |
| 83986 | 62 | 52 | $76.43 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 15 | 12 | $68.66 |
| 82150 | 31 | 24 | $67.62 | |
| 93356 | 19 | 13 | $64.11 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 105 | 87 | $63.77 |
| 86780 | 12 | 12 | $63.75 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 49 | 39 | $54.30 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 14 | 12 | $50.24 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 728 | 646 | $38.37 |
| 88304 | 68 | 37 | $33.66 | |
| 85046 | 22 | 13 | $26.73 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 77 | 59 | $16.53 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 27 | 12 | $14.00 |
| 83540 | 13 | 13 | $11.67 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 17 | 15 | $10.75 |
| 83550 | 12 | 12 | $9.56 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 178 | 168 | $5.49 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 228 | 199 | $0.95 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 12 | 12 | $0.72 |
| 0353U | 314 | 292 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 306 | 233 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 307 | 235 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 43 | 40 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 55 | 50 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 116 | 92 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 118 | 84 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 118 | 84 | $0.00 |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 26 | 13 | $0.00 |